SABBY CLSXY 13G 09.24.13

Company

Akari Therapeutics Plc

Filed

September 24, 2013

Accession Number

0001535610-13-000050

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →